摘要
目的:观察分析研究稳心颗粒和普罗帕酮联合应用治疗早搏的临床疗效。方法:选取我院2011年1月1日-2013年12月30日收治的早搏患者140例,随机分成两组,中西医结合治疗治疗组70例采用稳心颗粒和普罗帕酮联合应用治疗及西医治疗对照组70例单用普罗帕酮治疗。治疗1个月,比较两组的治疗效果。结果:1个月后经分析计算统计中西医结合治疗组及西医治疗对照组的总有效率分别92.9%和77.1%,两组总有效率差异显著,具有统计学意义(P<0.05),且治疗组出现的不良反应轻。结论:采用稳心颗粒和普罗帕酮联合应用治疗早搏临床效果显著、安全有效,有较高的临床应用价值。
Objective： To analyze clinical efficacy of Wenxin granule plus propafenone on premature beat. Methods： 140 patients in our hospital from January 1 2012 to December 30 2013 were randomly divided into the treatment group （70 cases were given Wenxin granule plus propafenone） and the control group （40 cases received propafenone）. Clinical effects in two groups were compared in 1 month. Results： In 1 month, the total efficacy in the treatment was 92.9%, in control was 77.1%; the difference was statistically significant （P〈0.05）. Adverse reactions were less. Conclusion： Wenxin granule plus propafenone were effective and safe on premature beat, and showed high value of clinical application.
出处
《中医临床研究》
2015年第1期74-74,76,共2页
Clinical Journal Of Chinese Medicine
关键词
室性早搏
稳心颗粒和普罗帕酮
临床价值
Premature ventricualr contraction
Wenxin granule plus propafenone
Clinical value
